Boehringer Ingelheim to Purchase Fremont Facility
Reaffirms FY 2011 Guidance
Asks FDA To Broaden Xgeva To Prostrate
Sees FY 2011 Guidance At High End Of Prior Guidance
Receives Enbrel Patent
Announces 2012 First Quarter Dividend
To Acquire Mustafa Nevzat Pharmaceuticals
Receives Complete Response Letter From FDA for XGEVA sBLA for Prevention of Bone Metastases
Completes Acquisition Of Mustafa Nevzat Pharmaceuticals
NPS Amends Royalty Agreement With Amgen Inc
Raises FY 2012 Guidance
Are Amgen Option Traders Switching
Brian Highest Pinnacle West Capital and Amgen
